Eleven substituted tricyclic quinazolines and their synthetic precursors were tested for antibacterial effects. 3-Chloromethylcarbonyl-2-methylquinazolin-4-thione and 5-phenyl-2,3-dihydro-1,2,4-triazolo[4,3-c]quinazolin-3-one had the highest antibacterial effect against Bacillus subtilis, the MIC values being 50 mg/L. Two tested derivatives were more active against Pseudomonas aeruginosa than ampicillin, the IC50 values being 80 and 100 mg/L. The most effective derivatives contained in the structure generally pharmacologically active chromophores--methyl group in position 2 and a chloromethyl configuration on the carbonyl group in position 3.

Department of Biochemistry and Microbiology Faculty of Chemical Technology Slovak University of Technology Bratislava Slovakia

See more in PubMed

Arch Pharm (Weinheim). 1990 Oct;323(10):833-6 PubMed

Farmaco. 1990 Apr;45(4):431-8 PubMed

Folia Microbiol (Praha). 1995;40(6):611-4 PubMed

Anticancer Drugs. 1997 Jan;8(1):3-16 PubMed

Farmaco. 1995 Dec;50(12):857-66 PubMed

Folia Biol (Praha). 1997;43(2):83-9 PubMed

J Chem Technol Biotechnol. 1992;53(4):329-36 PubMed

J Med Chem. 1986 Nov;29(11):2403-9 PubMed

Folia Microbiol (Praha). 1998;43(6):679-82 PubMed

J Med Chem. 1996 Mar 29;39(7):1433-7 PubMed

In vitro antimicrobial activity of 3,4-dihydro-s-triazinobenzimidazole derivatives

Antibacterial effects of trisubstituted quinazoline derivatives